Back to search

Article

Cause-Specific Mortality Following Sustained Virologic Response in hepatitis C patients Treated with Direct-Acting Antivirals: A Standardized Mortality Ratio Analysis

2025-10-29

Abstract excerpt

<title>Abstract</title> <p> Background Direct-acting antivirals (DAAs) achieve high sustained virologic response (SVR) rates in patients with hepatitis C virus (HCV) infection. However, the long-term prognosis and cause-specific mortality following SVR remain incompletely defined. Methods This study analyzed 1,753 HCV-infected patients without a history of hepatocellular carcinoma (HCC) treatment who achieved SV...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e07a2c21-8e0b-5c94-8a11-162073ff7395
DOI
10.21203/rs.3.rs-7721910/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cause-Specific Mortality Following Sustained Virologic Response in hepatitis C patients Treated with Direct-Acting Antivirals: A Standardized Mortality Ratio AnalysisDOI 10.21203/rs.3.rs-7721910/v1
The incidence of all organ malignancies and overall survival of patient with sustained virological response of HCVSemantic proximity
Effect of sustained viral clearance on liver-related mortality among individuals living with hepatitis C by treatment era: a population-based retrospective cohort studySemantic proximity
Causes of Death in Hepatocellular Carcinoma Patients: A SEER-Based StudySemantic proximity
Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral Therapy: A National Observational Cohort StudySemantic proximity
Long-Term Survival of Canadian Liver Transplant Recipients Remains Stagnant; a cohort study on the evolution of cause-specific mortality.Semantic proximity
DIRECT-ACTING ANTIVIRALS FOR HEPATITIS C DO NOT AFFECT THE RISK OF DEVELOPMENT OR THE OUTCOME OF HEPATOCELLULAR CARCINOMA.Semantic proximity
Effect of hepatitis C virus infection in patients with cancer: addressing a neglected population.Semantic proximity
Direct-acting antivirals are effective for chronic hepatitis C treatment in elderly patients: a real-world study of 17 487 patients.Semantic proximity
Lower incidence of hepatocellular carcinoma and cirrhosis in hepatitis C patients with sustained virological response by pegylated interferon and ribavirin.Semantic proximity
Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation.Semantic proximity
Associations between serum levels of liver function biomarkers and all-cause and cause-specific mortality: A prospective cohort studySemantic proximity
The number needed to treat to prevent mortality and cirrhosis-related complications among patients with cirrhosis and HCV genotype 1 infection.Semantic proximity
Select a neighboring publication to make it the new centre.